Literature DB >> 11384551

Etiology and Management of Acute and Recurrent Group A Streptococcal Tonsillitis.

Asher Barzilai1, Dan Miron, Shlomo Sela.   

Abstract

Tonsillitis is one of the most prevalent infections in children and adolescents. The etiologic agents might be viral or bacterial. About 30% of cases are reported to be of bacterial origin, mainly due to group A Streptococcus (GAS). Although in most instances GAS tonsillitis is a self-limited disease, antibiotic treatment is recommended, mainly to prevent the suppurative and nonsuppurative poststreptococcal sequelae of acute rheumatic fever and to prevent glomerulonephritis. In this paper we review the current knowledge of the etiology of acute and recurrent GAS tonsillitis, with special emphasis on a recent hypothesis regarding the etiology of bacterial eradication failure. While penicillin V remains the drug of choice for acute tonsillitis, other antibiotics are being approved and recommended for particular indications in both Europe and the United States.

Entities:  

Year:  2001        PMID: 11384551     DOI: 10.1007/s11908-001-0023-6

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  65 in total

1.  Relationship between asymptomatic carriage of Streptococcus pyogenes and the ability of the strains to adhere to and be internalised by cultured epithelial cells.

Authors:  Shlomo Sela; Revital Neeman; Nattan Keller; Asher Barzilai
Journal:  J Med Microbiol       Date:  2000-06       Impact factor: 2.472

2.  Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection.

Authors:  H M Schrager; J G Rheinwald; M R Wessels
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 3.  Optimum treatment of streptococcal pharyngitis.

Authors:  F Scaglione; G Demartini; M M Arcidiacono; J P Pintucci
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

4.  Bacterial interference. II. Role of the normal throat flora in prevention of colonization by group A Streptococcus.

Authors:  C C Crowe; W E Sanders; S Longley
Journal:  J Infect Dis       Date:  1973-10       Impact factor: 5.226

5.  An intracellular sanctuary for Streptococcus pyogenes in human tonsillar epithelium--studies of asymptomatic carriers and in vitro cultured biopsies.

Authors:  A Osterlund; L Engstrand
Journal:  Acta Otolaryngol       Date:  1997-11       Impact factor: 1.494

6.  Roles of integrins and fibronectin in the entry of Streptococcus pyogenes into cells via protein F1.

Authors:  V Ozeri; I Rosenshine; D F Mosher; R Fässler; E Hanski
Journal:  Mol Microbiol       Date:  1998-11       Impact factor: 3.501

7.  Investigation of oral alpha-streptococcus showing inhibitory activity against pathogens in children with tonsillitis.

Authors:  I Fujimori; R Goto; K Kikushima; K Hisamatsu; Y Murakami; T Yamada
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1995-11       Impact factor: 1.675

8.  Ceftibuten vs. penicillin V in group A beta-hemolytic streptococcal pharyngitis. Members of the Ceftibuten Pharyngitis International Study Group.

Authors:  M E Pichichero; S E Mclinn; W M Gooch; W Rodriguez; J Goldfarb; B E Reidenberg
Journal:  Pediatr Infect Dis J       Date:  1995-07       Impact factor: 2.129

9.  Once-daily therapy for streptococcal pharyngitis with amoxicillin.

Authors:  H M Feder; M A Gerber; M F Randolph; P S Stelmach; E L Kaplan
Journal:  Pediatrics       Date:  1999-01       Impact factor: 7.124

10.  Role of bacterial interference and beta-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis.

Authors:  I Brook; A E Gober
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1995-12
View more
  1 in total

Review 1.  Paediatric Autoimmune Neuropsychiatric Disorder Associated with Group A Beta-Haemolytic Streptococcal Infection: An Indication for Tonsillectomy? A Review of the Literature.

Authors:  Amarkumar Dhirajlal Rajgor; Navid Akhtar Hakim; Sanah Ali; Adnan Darr
Journal:  Int J Otolaryngol       Date:  2018-02-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.